Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Return on Equity [ROE] (2018)

Updated

Sanofi's Return on Equity [ROE] was 7.37% in the year ended Dec 31, 2023.

Analysis

Sanofi (SNY) Return on Equity [ROE] (2018) Analysis & Trends

From the year ended Dec 31, 2009 onward, Sanofi has reported Return on Equity [ROE] for 14 years.

  • Return on Equity [ROE] shows a five-year change of -0.17 percentage points (years ended Dec 2018 to Dec 2023).
  • The figure for the year ended Dec 31, 2023 marks the lowest annual Return on Equity [ROE] since the year ended Dec 31, 2019.
  • Per Business Quant data, Return on Equity [ROE] in earlier years was 9.66% in the year ended Dec 31, 2021 (-10.67 pp), 20.32% in the year ended Dec 31, 2020 (+17.40 pp) and 2.92% in the year ended Dec 31, 2019 (-4.62 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 19.33%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 7.21%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 31.52%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 21.39%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -18.38%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 4.97%
10 Sanofi 50.63 Bn 17.15 Bn 10.79 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 6.38%
API Access

Sanofi Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY